Metro Region: San Francisco Bay Area
Member Since: 2022
Dr. Kang completed his medical degree and public health degree at Yonsei University in Seoul, South Korea, then came to the US and had residency training at St. Luke’s Roosevelt Hospital Center/Columbia University in New York City. He completed his hematology and medical oncology fellowship at Emory University in Atlanta, GA.
Dr. Kang’s research focus is the development of clinical trials with novel therapeutic agents for patients with head and neck cancers. He played a pivotal role in the development of immune checkpoint inhibitors in head and neck cancers and conducted/participated in a number of clinical trials. His current research focus is developing novel therapeutics for rare cancers of head and neck such as salivary gland cancers and thyroid cancers based on precision oncology and cancer genomics.